119 data-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "UCL" "UCL" "UCL" "UCL" "UCL" Postdoctoral research jobs at University of Oxford
Sort by
Refine Your Search
-
-learning models based on first-principles data and apply these methods across increasingly complex structures and chemical systems. The role will involve both methodological development (datasets, models
-
role focuses on the computational analysis and methodological development of third-generation and single-cell sequencing data to understand the role of transposable elements (TEs) in early mammalian
-
computational biologists, immunologists, clinicians, and experimental scientists, you will support study design, data interpretation, and reporting, and contribute to the development of robust, reproducible
-
it is imperative that samples are promptly received and processed in a timely and rigorous manner, and all data and methodology is recorded in an organised and precise manner electronically
-
ability to write clean, well-documented analysis code. Ability to work with EEG data and apply multivariate methods to extract meaningful measures relevant to memory and consolidation. Skilled in developing
-
demonstrable molecular biology skills. You will be able to design the experiments, execute the experiment using various molecular biology techniques, and help analyse the data. You will have highly effective
-
on patient perspectives and aims to understand the information older people need about the harms and benefits of prostate specific antigen (PSA) testing (ProsDetect II). The second project addresses challenges
-
team working skills. Informal enquiries may be addressed to Prof Ioannis Havoutis (email: Ioannis.havoutis@eng.ox.ac.uk subject tag [PDRA Robot Scouting]) For more information about working at
-
the ability to design and manage independent research, analyse and publish complex biological data, and work effectively within a collaborative team environment. An interest in translational science and drug
-
of human samples collected as part of this clinical trial must comply with the Medicines for Human Use (Clinical Trials) Regulations 2004 and will provide the primary endpoint data that will dictate